Survival analysis based on the expression level of EFNB2 revealed a significant decrease in the survival time of patients with CRC LM who had high EFNB2 expression, compared with those with low EFNB2 expression in LM tissues (Fig. 7A). Here, EFNB2 is linked to colorectal carcinoma.